Bio-Path Holdings, Inc. short interest in 2019
In 2019, Bio-Path Holdings, Inc.'s disclosed short interest ran from 1.06% of shares outstanding on 15 Jan 2019 to 4.63% on 31 Dec 2019, a change of +3.57 percentage points. The year's high was 23.93% on 15 Mar 2019 and its low 1.06% on 15 Jan 2019, averaging 9.07% across 21 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 4.63 days on 13 Sep 2019. Full history: Bio-Path Holdings, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024
2019 in figures
- Start of year
- 1.06% (15 Jan 2019)
- End of year
- 4.63% (31 Dec 2019)
- Change
- +3.57 pp
- High
- 23.93% (15 Mar 2019)
- Low
- 1.06% (15 Jan 2019)
- Average
- 9.07%
- Highest days to cover
- 4.63 (13 Sep 2019)
- SEC filings marked
- 8
Every report in 2019
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2019 | 1.06% | 1.00 | |
| 15 Mar 2019 | 23.93% | 1.00 | |
| 29 Mar 2019 | 17.09% | 1.00 | 10-K filed, results (8-K) |
| 15 Apr 2019 | 15.14% | 1.00 | |
| 30 Apr 2019 | 14.97% | 1.08 | |
| 15 May 2019 | 11.98% | 1.27 | 10-Q filed |
| 31 May 2019 | 11.75% | 2.09 | results (8-K) |
| 14 Jun 2019 | 10.55% | 1.37 | |
| 28 Jun 2019 | 8.26% | 3.56 | |
| 15 Jul 2019 | 9.37% | 1.13 | |
| 31 Jul 2019 | 9.85% | 1.00 | |
| 15 Aug 2019 | 8.87% | 3.12 | 10-Q filed, results (8-K) |
| 30 Aug 2019 | 8.08% | 3.07 | |
| 13 Sep 2019 | 6.83% | 4.63 | |
| 30 Sep 2019 | 6.28% | 2.89 | |
| 15 Oct 2019 | 4.53% | 2.06 | |
| 31 Oct 2019 | 4.88% | 1.96 | |
| 15 Nov 2019 | 2.87% | 1.56 | 10-Q filed, results (8-K) |
| 29 Nov 2019 | 5.02% | 1.00 | |
| 13 Dec 2019 | 4.62% | 1.00 | |
| 31 Dec 2019 | 4.63% | 1.09 |
See also: Bio-Path Holdings, Inc.'s full history · most shorted US stocks of 2019 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.